Bangladesh vs Guinea: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Guinea
44.93
in 2021
Bangladesh rank
121st
Guinea rank
120th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Guinea
How they compare
Guinea currently reports 44.93 against 43.54 in Bangladesh, a difference of 1.39.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 121st and Guinea ranks 120th of 146 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 17.48 | 8.62 | Bangladesh |
| 2020s | 39.25 | 23.42 | 15.84 | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Guinea?
- Guinea, at 44.93 against 43.54 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Guinea?
- 1.39, with Guinea ahead.
- How many years of comparable data are there for Bangladesh and Guinea?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Guinea rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Guinea ranks 120th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.